Publikationen

Workshop-Dokumente (59th Annual Congress in Antalya, 2011)

Workshop 2: Workshop of the Permanent Committee on Biological and Pharmacological Activity of Natural Products: "Natural Herbs & dietary supplements for the management of Metabolic Syndrome"

• Identification of PPARɣ agonists from natural sources by K. Christensen
• Genetic & nutrient determinants of the Metabolic Syndrome (Nutrigenomics) by H. Daniel

Workshop 3 of the Permanent Committee on Regulatory Affairs of Herbal Medicinal Products: "What regulation for botanical food supplements and (traditional) herbal medicinal products in the European Union: Is a harmonization between the member states possible?"

• Regulatory Options for (Traditional) Herbal Medicinal Products by W. Knoess
• Botanical Food Supplements: Regulatory Situation in the EU by P. Coppens
• Quality of Herbal Medicinal Products and Food Supplements: EU Regulation and Practical Experience by H. Sievers
• Traditional Herbal Drugs and Botanical Dietary Supplements: The Italian Experience by P. Morazzoni

Workshop 6: Workshop of the Permanent Committees on Breeding and Cultivation of Medicinal Plants and Manufacturing and Quality Control of HMPs: “Contaminants in starting materials from an industrial and production point of view”

• Introduction by C. Erdelmeier
• Environmental Contaminants - Heavy Metals Origin - Analytical Methods - Points to Consider by A. Hofmann
• The Application of Pesticides in the Production of Medicinal Plants in China by M. Yang
• Legal requirements for the control of contaminants in herbal medicinal products by B. Steinhoff
• Pesticide testing according to the European Pharmacopoeia (Ph.Eur.) - legal requirements and practical approach by B. Klier

Workshop-Dokumente (58th Annual Congress in Berlin, 2010)

Workshop 3 of the Permanent Committee on Regulatory Affairs of Herbal Medicinal Products: "The importance of a risk-benefit analysis for the marketing authorization and/or registration of (traditional) herbal medicinal products (HMPs)."

• Introduction by A. Vlietinck
• European practice: experiences with a risk-benefit analysis of HMPs for the elaboration of ESCOP monographs by B. Steinhoff
• European practice: Well-established use of herbal medicinal products and clinical research by G. Meng

Workshop-Dokumente (57th Annual Congress in Geneva, 2009)

Workshop 3 of the Permanent Committees on Manufacturing and Quality Control of Herbal Remedies and on Regulatory Affairs of Herbal Medicinal Products: "How useful are herbal extracts of the European Pharmacopoeia for the development of herbal medicinal products?"

• Solvents and phytochemical profiles of selected herbal extract monographs of Ph Eur. and the consequences for the equivalence of Herbal Medicinal Preparations by B. Meier
• The importance of extract monographs of the European Pharmacopoeia for the quality reviewer in Switzerland by B. Heneka
• Viewpoint of the European Pharmacopoeia by M. Wierer
• Herbal Extracts of the European Pharmacopoeia - Viewpoint of the European Regulators by R. Länger
• Viewpoint of the pharmaceutical industry by K. Helliwell

Workshop 5 of the Permanent Committee on Breeding and Cultivation of Medical Plants: "Genetic Resources, Conservation and Breeding"

• Medicinal and Aromatic Plants (MAPs) Conservation Programme in Europe by D. Baričevič
• Genetic Resources, Conservation and Breeding by C. Carlen

Workshop-Dokumente (56th Annual Congress in Athen, 2008)

Workshop of the GA on Regulatory Affairs on Herbal Medicinal Products: Medicinal Herbs: drugs or dietary supplements? What are the legal consequences in terms of quality, safety and efficacy of each option?

• Introduction by S. Alban
• Viewpoint of the European Regulatory Authorities by A. Vlietinck
• Viewpoint of the German Regulatory Authorities by W. Knöss
• Viewpoint of the European Pharmaceutical Industry by H. Sievers
• Viewpoint of the US Regulatory Authorities by V. Frankos
• Viewpoint of the US Industry by M. McGuffin

Workshop-Dokumente (55th Annual Congress in Graz, 2007)

Workshop 1 of the Permanent Committee on Regulatory Affairs of HMPs: "Importance of HMPC community monographs and community list entries for the marketing authorisation and registration of herbal medicinal products in Europe"

• Introduction by A.J. Vlietinck
• European regulator's perspective on implementation by K. Keller
• National regulator's perspective on implementation by H. Pittner
• Phytotherapeutical association's perspective on implementation by B. Steinhoff
• Viewpoint of the pharmaceutical industry by B. Roether
• Viewpoint of the producers of food supplements by P. Coppens

Workshop 2 of the Permanent Committee on Manufacturing and Quality Control of Herbal Remedies: "Pharmacokinetics of herbal medicinal products - useful or not?"

• Introduction by B. Meier
• View of the national competent authority of Austria (AGES PharmMed) by R. Länger
• Pharmacokinetics of different Echinacea purpurea Moench and Ginkgo biloba L. preparations by K. Wölkart
• Pharmacokinetics of HMPs - The industrial R&D perspective by F. Lang

Workshop 3 of the Permanent Committee on Biological and Pharmacological Activity of Natural Products: "Models for testing addictive behaviour"

• Operant animal models for drug-seeking behaviour by P. Bäckström

Workshop 4 of the Permanent Committee on Breeding and Cultivation of Medical Plants: "Identification and authentication of plant starting materials"

• Current problems with the identification of herbal drugs by B. Klier
• HPTLC for identification and quality control of medicinal plants by E. Reich
• DNA based identification and authentication of medicinal plants and extracts by J. Novak

Workshop-Dokumente (54th Annual Congress in Helsinki, 2006)

Workshop 2 of the Permanent Committee on Breeding and Cultivation of Medical Plants: "Plant Intellectual Property Rights"

• Plant Intellectual Property Rights by Ch. Franz
• ProBenefit by C. Krück

Workshop 2 of the Permanent Committee on Manufacturing and Quality Control of Herbal Medicinal Products: "Reference Compounds"

• How much of Quality and Identity do we need? by K. Reif
• European Pharmacopoeia Reference Standards for Herbal Drugs and Preparations by U. Rose
• Quality Control Botanicals by R. Verpoorte

Workshop-Dokumente (53rd Annual Congress in Florence, 2005)

Workshop 1 of the Permanent Committee on Manufacturing and Quality Control of Herbal Remedies: "The Practice of Dissolution Testing in Herbal Medicinal Products"

• Dissolution testing of herbal medicinal products - Viewpoint of the regulatory authority by W. Knoess
• The impact of dosage forms by A.R. Bilia
• HMPs containing comminuted herbal drugs by H. Sievers

Workshop 3 of the Permanent GA Committee on Regulatory Affairs of HMPs: "How to implement the new legislation on HMPs in Europe?"

• Introduction by A.J. Vlietinck
• Viewpoint of the European regulatory authorities by K. Keller
• Viewpoint of the national regulatory authorities by V. Silano
• Viewpoint of the pharmaceutical industry by L. Kabelitz

Workshop 4 of the Permanent GA Committee on Breeding and Cultivation of Medical Plants: "Good Practices, Standards and Certifications of Starting Materials"

• Development of an International Standard for Sustainable Wild Collection of Medicinal and Aromatic Plants (ISSC-MAP) by B. Pätzold
• Good Agricultural Practice and Good Wildcrafting Practice, present and future by R. Iguera
• Good Practices, Standards and Certification of Starting Materials - Contribution of the Herbal Medicinal Products Industry (AESGP) by B. Steinhoff